Monte Rosa TherapeuticsGLUE
13F holders, Q2 2026 (June 30)192holders +1
26new positions
23sold out
6famous investors
$24.19avg. 13F price*
At the end of Q2 2026, 192 institutions reported holding Monte Rosa Therapeutics Inc. (GLUE) in their 13F filings, up 1 from Q1 2026. 26 opened new positions and 23 sold out. The largest holders were T. Rowe Price Associates Inc. ($214.4M), NEA Management Company, LLC ($186.2M) and BlackRock, Inc. ($165.6M). 6 famous investors held it, including Stanley Druckenmiller (0.2% of Duquesne Family Office's portfolio), Cliff Asness (0.0% of AQR Capital Management's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Monte Rosa Therapeutics Inc.
- CUSIP
- 61225M102
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 26 | $77.5M |
| Exits | 23 | $28.9M |
All 13F filers, Q1 2026 → Q2 2026: 13,072,481 shares bought and 7,713,206 shares sold, net +5,359,275 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 192 holders
| T. Rowe Price Associates Inc. | 0.02% | Add +31.9% | 8,861,171 | $214.4M |
| NEA Management Company, LLC | 11.72% | No change | 7,692,298 | $186.2M |
| BlackRock, Inc. | 0.00% | Add +21.4% | 6,843,087 | $165.6M |
| TCG Crossover Management, LLC | 2.69% | No change | 4,622,151 | $111.9M |
| Vestal Point Capital, LP | 2.60% | Add +27.6% | 4,600,000 | $111.3M |
| BVF Inc. | 2.76% | No change | 4,460,886 | $108.0M |
| Baker Bros. Advisors LP | 0.53% | No change | 4,345,736 | $105.2M |
| State Street Corp. | 0.00% | Add +11.3% | 3,731,416 | $90.3M |
| Montanova Capital, LLC | 1.81% | Reduce -16.0% | 3,549,539 | $85.9M |
| Vanguard Capital Management LLC | 0.00% | Add +10.1% | 3,412,927 | $82.6M |
| Versant Venture Management, LLC | 47.34% | No change | 3,180,780 | $77.0M |
| Braidwell LP | 2.28% | Reduce -23.6% | 2,451,562 | $59.3M |
| Geode Capital Management, LLC | 0.00% | Add +21.0% | 1,864,113 | $45.1M |
| American Century Companies Inc. | 0.02% | Reduce -42.2% | 1,622,846 | $39.3M |
| Marshall Wace, LLP | 0.03% | Add +11.2% | 1,593,600 | $38.6M |
| Aisling Capital Management LP | 7.98% | No change | 1,555,664 | $37.6M |
| Bellevue Group AG | 0.61% | Reduce -4.8% | 1,190,000 | $28.8M |
| Dimensional Fund Advisors LP | 0.01% | Add +13.1% | 1,177,488 | $28.5M |
| MPM Bioimpact LLC | 1.71% | Reduce -1.4% | 1,161,081 | $28.1M |
| Silverarc Capital Management, LLC | 2.98% | Reduce -44.6% | 1,108,295 | $26.8M |
| Jupiter Topco LLC | 0.01% | — | 1,072,494 | $26.0M |
| Frazier Life Sciences Management, L.P. | 0.53% | No change | 1,000,000 | $24.2M |
| Goldman Sachs Group Inc. | 0.00% | Reduce -0.3% | 998,253 | $24.2M |
| Woodline Partners LP | 0.07% | Add +1192.5% | 962,884 | $23.3M |
| FMR LLC | 0.00% | Reduce -8.8% | 934,414 | $22.6M |
| Vanguard Portfolio Management LLC | 0.00% | Add +53.5% | 791,932 | $19.2M |
| Morgan Stanley | 0.00% | Add +15.4% | 789,545 | $19.1M |
| Nextech Invest Ltd. | 0.87% | Add +150.2% | 761,153 | $18.4M |
| Opaleye Management Inc. | 1.63% | New | 745,000 | $18.0M |
| Northern Trust Corp. | 0.00% | Reduce -21.1% | 652,087 | $15.8M |
| Nantahala Capital Management, LLC | 0.96% | No change | 651,993 | $15.8M |
| First Trust Advisors LP | 0.01% | New | 647,796 | $15.7M |
| Charles Schwab Investment Management Inc. | 0.00% | Add +12.7% | 616,310 | $14.9M |
| Boone Capital Management LLC | 3.48% | New | 615,287 | $14.9M |
| Bridgeway Capital Management, LLC | 0.23% | Add +4.5% | 552,566 | $13.4M |
| AQR Capital Management | 0.00% | Reduce -20.9% | 520,648 | $12.6M |
| Vanguard Fiduciary Trust Co. | 0.00% | Add +24.2% | 505,500 | $12.2M |
| Parkwood LLC | 0.88% | No change | 505,000 | $12.2M |
| Adage Capital Partners Gp, L.L.C. | 0.02% | Add +80.0% | 450,000 | $10.9M |
| Kennedy Capital Management LLC | 0.17% | Add +1168.2% | 405,529 | $9.8M |
| Ameriprise Financial Inc. | 0.00% | Add +964.9% | 383,335 | $9.3M |
| Alphabet Inc. | 0.01% | Reduce -45.6% | 372,474 | $9.0M |
| Fisher Asset Management | 0.00% | Add +15.4% | 363,520 | $8.8M |
| Allspring Global Investments Holdings, LLC | 0.01% | Reduce -10.0% | 352,857 | $8.5M |
| Empowered Funds, LLC | 0.04% | Add +7.8% | 329,266 | $8.0M |
| Duquesne Family Office | 0.17% | New | 297,600 | $7.2M |
| TD Asset Management Inc | 0.01% | Reduce -0.4% | 285,936 | $6.9M |
| Bank of America Corp. | 0.00% | Reduce -34.3% | 254,561 | $6.2M |
| Bank of New York Mellon Corp | 0.00% | Add +8.7% | 222,521 | $5.4M |
| Longaeva Partners L.P. | 0.15% | New | 216,792 | $5.2M |
| ADAR1 Capital Management, LLC | 0.25% | Add +0.5% | 216,752 | $5.2M |
| Wellington Management Group LLP | 0.00% | Add +61.1% | 207,427 | $5.0M |
| UBS Group AG | 0.00% | Add +31.6% | 200,833 | $4.9M |
| Nomura Asset Management International Inc. | 0.01% | No change | 200,000 | $4.8M |
| Balyasny Asset Management L.P. | 0.01% | Reduce -22.5% | 198,895 | $4.8M |
| Manufacturers Life Insurance Company, The | 0.00% | Reduce -8.5% | 191,877 | $4.6M |
| Franklin Resources Inc. | 0.00% | Reduce -5.5% | 188,833 | $4.6M |
| Casdin Capital, LLC | 0.23% | No change | 186,014 | $4.5M |
| D. E. Shaw & Co. | 0.00% | Add +159.4% | 172,053 | $4.2M |
| Victory Capital Management Inc. | 0.00% | Add +9.0% | 168,512 | $4.1M |
| Nuveen, LLC | 0.00% | Add +38.0% | 166,758 | $4.0M |
| Citadel Advisors | 0.00% | Reduce -35.7% | 163,571 | $4.0M |
| Voya Investment Management LLC | 0.00% | Add +90.2% | 156,633 | $3.8M |
| Stempoint Capital LP | 0.64% | New | 153,544 | $3.7M |
| Two Sigma Investments, LP | 0.00% | Add +630.2% | 140,923 | $3.4M |
| Exome Asset Management LLC | 2.05% | Reduce -23.6% | 137,115 | $3.3M |
| Citigroup Inc. | 0.00% | Add +788.3% | 129,467 | $3.1M |
| ExodusPoint Capital Management, LP | 0.03% | New | 121,121 | $2.9M |
| Trexquant Investment LP | 0.02% | Add +134.6% | 115,363 | $2.8M |
| Caption Management, LLC | 0.10% | New | 112,322 | $2.7M |
| Atom Investors LP | 0.24% | Reduce -42.9% | 111,012 | $2.7M |
| Jain Global LLC | 0.03% | New | 110,647 | $2.7M |
| Renaissance Technologies | 0.00% | Reduce -73.0% | 102,500 | $2.5M |
| Invesco Ltd. | 0.00% | Reduce -5.1% | 97,013 | $2.3M |
| Swiss National Bank | 0.00% | Add +57.6% | 96,300 | $2.3M |
| Rhumbline Advisers | 0.00% | Add +23.8% | 94,593 | $2.3M |
| Squarepoint Ops LLC | 0.00% | Add +123.5% | 82,953 | $2.0M |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 0.00% | Add +418.7% | 79,122 | $1.9M |
| Diadema Partners LP | 0.72% | Reduce -58.1% | 78,391 | $1.9M |
| JPMorgan Chase & Co. | 0.00% | Add +13.8% | 76,820 | $1.8M |
| Deutsche Bank AG | 0.00% | Add +56.8% | 75,061 | $1.8M |
| Wells Fargo & Company | 0.00% | Add +195.8% | 68,650 | $1.7M |
| State of Wisconsin Investment Board | 0.00% | Reduce -10.1% | 66,706 | $1.6M |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 0.00% | Add +239.5% | 65,451 | $1.6M |
| Alliancebernstein L.P. | 0.00% | Add +57.0% | 87,420 | $1.4M |
| Rafferty Asset Management, LLC | 0.00% | Reduce -43.8% | 58,755 | $1.4M |
| Tetragon Partners GP Ltd | 0.22% | New | 56,052 | $1.4M |
| Massachusetts Financial Services Co. | 0.00% | Reduce -3.8% | 54,328 | $1.3M |
| Quantinno Capital Management LP | 0.00% | Add +0.4% | 54,199 | $1.3M |
| California State Teachers Retirement System | 0.00% | Add +1547.8% | 54,196 | $1.3M |
| Sei Investments Co. | 0.00% | Reduce -35.6% | 50,028 | $1.2M |
| Principal Financial Group Inc. | 0.00% | Add +15.6% | 49,001 | $1.2M |
| Seven Grand Managers, LLC | 0.04% | No change | 45,000 | $1.1M |
| MetLife Investment Management, LLC | 0.00% | Add +30.3% | 43,529 | $1.1M |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 0.00% | Add +14.3% | 40,923 | $988K |
| Legal & General Group Plc | 0.00% | Add +66.0% | 40,376 | $977K |
| XTX Topco Ltd | 0.01% | Reduce -31.0% | 39,875 | $965K |
| Russell Investments Group, Ltd. | 0.00% | Add +424.8% | 38,774 | $938K |
| Vanguard Global Advisers, LLC | 0.00% | Add +7.3% | 38,635 | $935K |
| Round Rock Advisors LLC | 0.12% | No change | 37,229 | $901K |
"% of holder's portfolio" is GLUE's weight in each manager's 13F, not the share of Monte Rosa Therapeutics Inc. the manager owns.